159 related articles for article (PubMed ID: 36073930)
1. Kirenol alleviates diabetic nephropathy via regulating TGF-β/Smads and the NF-κB signal pathway.
Li J; Zhang J; Yang M; Huang X; Zhang M; Fang X; Wu S
Pharm Biol; 2022 Dec; 60(1):1690-1700. PubMed ID: 36073930
[TBL] [Abstract][Full Text] [Related]
2. Wogonin Ameliorates Renal Inflammation and Fibrosis by Inhibiting NF-κB and TGF-β1/Smad3 Signaling Pathways in Diabetic Nephropathy.
Zheng ZC; Zhu W; Lei L; Liu XQ; Wu YG
Drug Des Devel Ther; 2020; 14():4135-4148. PubMed ID: 33116403
[TBL] [Abstract][Full Text] [Related]
3. Polydatin ameliorates experimental diabetes-induced fibronectin through inhibiting the activation of NF-κB signaling pathway in rat glomerular mesangial cells.
Xie X; Peng J; Huang K; Huang J; Shen X; Liu P; Huang H
Mol Cell Endocrinol; 2012 Oct; 362(1-2):183-93. PubMed ID: 22732364
[TBL] [Abstract][Full Text] [Related]
4. Triptolide Improves Renal Injury in Diabetic Nephropathy Rats through TGF-β1/Smads Signal Pathway.
Pang R; Gu D
Endocr Metab Immune Disord Drug Targets; 2021; 21(10):1905-1911. PubMed ID: 34530721
[TBL] [Abstract][Full Text] [Related]
5. Apigenin ameliorates streptozotocin-induced diabetic nephropathy in rats via MAPK-NF-κB-TNF-α and TGF-β1-MAPK-fibronectin pathways.
Malik S; Suchal K; Khan SI; Bhatia J; Kishore K; Dinda AK; Arya DS
Am J Physiol Renal Physiol; 2017 Aug; 313(2):F414-F422. PubMed ID: 28566504
[TBL] [Abstract][Full Text] [Related]
6. Andrographolide ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated renal oxidative stress and inflammation via Akt/NF-κB pathway.
Ji X; Li C; Ou Y; Li N; Yuan K; Yang G; Chen X; Yang Z; Liu B; Cheung WW; Wang L; Huang R; Lan T
Mol Cell Endocrinol; 2016 Dec; 437():268-279. PubMed ID: 27378149
[TBL] [Abstract][Full Text] [Related]
7. Renal-protective effect of thalidomide in streptozotocin-induced diabetic rats through anti-inflammatory pathway.
Zhang H; Yang Y; Wang Y; Wang B; Li R
Drug Des Devel Ther; 2018; 12():89-98. PubMed ID: 29386886
[TBL] [Abstract][Full Text] [Related]
8. Fucoidan exerts protective effects against diabetic nephropathy related to spontaneous diabetes through the NF-κB signaling pathway in vivo and in vitro.
Wang Y; Nie M; Lu Y; Wang R; Li J; Yang B; Xia M; Zhang H; Li X
Int J Mol Med; 2015 Apr; 35(4):1067-73. PubMed ID: 25672488
[TBL] [Abstract][Full Text] [Related]
9. GdCl
Li J; Wu B; Hu H; Fang X; Liu Z; Wu S
J Pharmacol Sci; 2020 Feb; 142(2):41-49. PubMed ID: 31831259
[TBL] [Abstract][Full Text] [Related]
10. Effects of berberine on matrix accumulation and NF-kappa B signal pathway in alloxan-induced diabetic mice with renal injury.
Liu W; Zhang X; Liu P; Shen X; Lan T; Li W; Jiang Q; Xie X; Huang H
Eur J Pharmacol; 2010 Jul; 638(1-3):150-5. PubMed ID: 20447389
[TBL] [Abstract][Full Text] [Related]
11. Carnosic acid improves diabetic nephropathy by activating Nrf2/ARE and inhibition of NF-κB pathway.
Xie Z; Zhong L; Wu Y; Wan X; Yang H; Xu X; Li P
Phytomedicine; 2018 Aug; 47():161-173. PubMed ID: 30166101
[TBL] [Abstract][Full Text] [Related]
12. Combination of leflunomide and benazepril reduces renal injury of diabetic nephropathy rats and inhibits high-glucose induced cell apoptosis through regulation of NF-κB, TGF-β and TRPC6.
Li H; Wang Y; Zhou Z; Tian F; Yang H; Yan J
Ren Fail; 2019 Nov; 41(1):899-906. PubMed ID: 31552773
[No Abstract] [Full Text] [Related]
13. Geniposide alleviates diabetic nephropathy of mice through AMPK/SIRT1/NF-κB pathway.
Li F; Chen Y; Li Y; Huang M; Zhao W
Eur J Pharmacol; 2020 Nov; 886():173449. PubMed ID: 32758570
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of ginsenoside metabolite compound K against diabetic nephropathy by inhibiting NLRP3 inflammasome activation and NF-κB/p38 signaling pathway in high-fat diet/streptozotocin-induced diabetic mice.
Song W; Wei L; Du Y; Wang Y; Jiang S
Int Immunopharmacol; 2018 Oct; 63():227-238. PubMed ID: 30107367
[TBL] [Abstract][Full Text] [Related]
15. Bergenin ameliorates diabetic nephropathy in rats via suppressing renal inflammation and TGF-β1-Smads pathway.
Yang J; Kan M; Wu GY
Immunopharmacol Immunotoxicol; 2016; 38(2):145-52. PubMed ID: 26954391
[TBL] [Abstract][Full Text] [Related]
16. Monocyte chemoattractant protein-1 has prosclerotic effects both in a mouse model of experimental diabetes and in vitro in human mesangial cells.
Giunti S; Tesch GH; Pinach S; Burt DJ; Cooper ME; Cavallo-Perin P; Camussi G; Gruden G
Diabetologia; 2008 Jan; 51(1):198-207. PubMed ID: 17968528
[TBL] [Abstract][Full Text] [Related]
17. Pterostilbene Ameliorates Nephropathy Injury in Streptozotocin-Induced Diabetic Rats.
Zhang Y; Ren S; Ji Y; Liang Y
Pharmacology; 2019; 104(1-2):71-80. PubMed ID: 31117104
[TBL] [Abstract][Full Text] [Related]
18. Repression of let-7 by transforming growth factor-β1-induced Lin28 upregulates collagen expression in glomerular mesangial cells under diabetic conditions.
Park JT; Kato M; Lanting L; Castro N; Nam BY; Wang M; Kang SW; Natarajan R
Am J Physiol Renal Physiol; 2014 Dec; 307(12):F1390-403. PubMed ID: 25354942
[TBL] [Abstract][Full Text] [Related]
19. Huangkui capsule in combination with metformin ameliorates diabetic nephropathy via the Klotho/TGF-β1/p38MAPK signaling pathway.
Gu LY; Yun-Sun ; Tang HT; Xu ZX
J Ethnopharmacol; 2021 Dec; 281():113548. PubMed ID: 33152427
[TBL] [Abstract][Full Text] [Related]
20. Gentiopicroside activates the bile acid receptor Gpbar1 (TGR5) to repress NF-kappaB pathway and ameliorate diabetic nephropathy.
Xiao H; Sun X; Liu R; Chen Z; Lin Z; Yang Y; Zhang M; Liu P; Quan S; Huang H
Pharmacol Res; 2020 Jan; 151():104559. PubMed ID: 31759089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]